DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Malathionis the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Suven Pharms, and Taro Pharm Inds Ltd, and is included in three NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Malathion has ten patent family members in seven countries.
There are three drug master file entries for malathion. Two suppliers are listed for this compound.
Summary for MALATHION
|Drug Master File Entries:||3|
|Suppliers / Packagers:||2|
|Bulk Api Vendors:||64|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price trends for MALATHION|
|Drug Sales Revenues:||Drug sales revenues for MALATHION|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for MALATHION|
|DailyMed Link:||MALATHION at DailyMed|
Recent Clinical Trials for MALATHION
Identify potential brand extensions & 505(b)(2) entrants
|London School of Hygiene and Tropical Medicine||Phase 3|
|Taro Pharmaceuticals USA||Phase 1|
|Taro Pharmaceuticals USA||Phase 2/Phase 3|
Pharmacology for MALATHION
|Drug Class||Cholinesterase Inhibitor |
|Mechanism of Action||Cholinesterase Inhibitors |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mylan Pharms Inc||MALATHION||malathion||LOTION;TOPICAL||078743-001||Mar 6, 2009||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Taro Pharm Inds Ltd||OVIDE||malathion||LOTION;TOPICAL||018613-001||Aug 2, 1982||DISCN||Yes||No||Start Trial||Start Trial||Y||Start Trial|
|Taro Pharm Inds Ltd||OVIDE||malathion||LOTION;TOPICAL||018613-001||Aug 2, 1982||DISCN||Yes||No||Start Trial||Start Trial||Y||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.